ANTI-INSULIN ANTIBODY side effect
What is ANTI-INSULIN ANTIBODY ?ANTI-INSULIN ANTIBODY : Novolin Side Effects Report #5580120-9
Consumer or non-health professional from JAPAN reported NOVOLIN R problem on Dec 21, 2007. Female patient, child 7 years of age, weighting 61.73 lb, was diagnosed with type 1 diabetes mellitus and was treated with NOVOLIN R. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody, hyperglycaemia, hypoglycaemia, . NOVOLIN R dosage: unknown. During the same period patient was treated with NOVOLIN N, NOVORAPID, NOVORAPID CHU, LANTUS. Patient recovered.
ANTI-INSULIN ANTIBODY : Novolin Side Effects Report #5591199-2
NOVOLIN R problem was reported by a Consumer or non-health professional from JAPAN on Jan 07, 2008. Female patient, child 7 years of age, weighting 61.73 lb, was diagnosed with type 1 diabetes mellitus and was treated with NOVOLIN R. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody, hyperglycaemia, hypoglycaemia, hypoglycaemic seizure, . NOVOLIN R dosage: unknown. During the same period patient was treated with NOVOLIN N, NOVORAPID, NOVORAPID CHU, LANTUS. Patient recovered.
ANTI-INSULIN ANTIBODY : Novorapid Side Effects Report #5541901-0
Consumer or non-health professional from JAPAN reported NOVORAPID problem on Nov 28, 2007. Male patient, 86 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody, diabetes mellitus inadequate control, hypoglycaemia, . NOVORAPID dosage: unknown. During the same period patient was treated with NOVOLIN R, NOVORAPID CHU FLEXPEN. Patient was hospitalized. Patient recovered.
ANTI-INSULIN ANTIBODY : Penfill Side Effects Report #5576811-6
PENFILL problem was reported by a Consumer or non-health professional from JAPAN on Dec 19, 2007. Female patient, 77 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with PENFILL. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody, blood glucose fluctuation, . PENFILL dosage: unknown. During the same period patient was treated with NOVORAPID, NOVORAPID CHU. Patient was hospitalized. Patient recovered.
ANTI-INSULIN ANTIBODY : Novorapid Side Effects Report #5507642-0
Consumer or non-health professional from JAPAN reported NOVORAPID CHU FLEXPEN problem on Oct 26, 2007. Male patient, 68 years of age, weighting 156.5 lb, was treated with NOVORAPID CHU FLEXPEN. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody, blood glucose increased, injection site pain, panniculitis, . NOVORAPID CHU FLEXPEN dosage: unknown. During the same period patient was treated with NOVOLIN N, NOVOLIN R, NOVOLIN R, CRAVIT, MUCOSOLVAN, PREDNISOLONE, SELBEX. Patient was hospitalized. Patient recovered.
ANTI-INSULIN ANTIBODY : Penfill Side Effects Report #5507647-X
PENFILL problem was reported by a Physician from JAPAN on Oct 24, 2007. Female patient, 58 years of age, was diagnosed with diabetes mellitus and was treated with PENFILL. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody, autoantibody positive, bladder perforation, blood glucose fluctuation, . PENFILL dosage: unknown. Patient was hospitalized. Patient recovered.
ANTI-INSULIN ANTIBODY : Novorapid Side Effects Report #5513694-4
Consumer or non-health professional from JAPAN reported NOVORAPID problem on Nov 01, 2007. Male patient, 60 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody, epididymal infection, hyperglycaemia, . NOVORAPID dosage: unknown. During the same period patient was treated with NOVOLIN U CHU, HUMALOG. Patient was hospitalized. Patient recovered.
ANTI-INSULIN ANTIBODY : Penfill Side Effects Report #5514229-2
PENFILL problem was reported by a Physician from JAPAN on Nov 02, 2007. Female patient, 58 years of age, was diagnosed with diabetes mellitus and was treated with PENFILL. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody, autoantibody positive, bladder perforation, blood glucose fluctuation, . PENFILL dosage: unknown. Patient was hospitalized. Patient recovered.
ANTI-INSULIN ANTIBODY : Humalog Side Effects Report #5519505-5
Physician from NETHERLANDS reported HUMALOG problem on Nov 02, 2007. Male patient was diagnosed with diabetes mellitus, hypertension, hypercholesterolaemia, impaired gastric emptying and was treated with HUMALOG. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody, hypoglycaemia, . HUMALOG dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, COZAAR, EZETROL, LESCOL, METOCLOPRAMIDE. Patient recovered.
ANTI-INSULIN ANTIBODY : Novorapid Side Effects Report #5521742-0
NOVORAPID problem was reported by a Consumer or non-health professional from JAPAN on Nov 12, 2007. Male patient, 60 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody, epididymal infection, hyperglycaemia, . NOVORAPID dosage: unknown. During the same period patient was treated with NOVOLIN U CHU, HUMALOG. Patient was hospitalized. Patient recovered.
ANTI-INSULIN ANTIBODY : Humalog Side Effects Report #5487584-X
Physician from NETHERLANDS reported HUMALOG problem on Oct 08, 2007. Male patient was diagnosed with type 1 diabetes mellitus, hypertension, hypercholesterolaemia, impaired gastric emptying and was treated with HUMALOG. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody, hypoglycaemia, . HUMALOG dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID, COZAAR, EZETROL, LESCOL, METOCLOPRAMIDE. Patient recovered.
ANTI-INSULIN ANTIBODY : Exubera Side Effects Report #5489967-0
EXUBERA problem was reported by a Consumer or non-health professional from BRAZIL on Oct 09, 2007. Female patient was diagnosed with diabetes mellitus and was treated with EXUBERA. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody, cough, hyperglycaemia, lung disorder, . EXUBERA dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
ANTI-INSULIN ANTIBODY : Exubera Side Effects Report #5501200-X
Consumer or non-health professional from BRAZIL reported EXUBERA problem on Oct 18, 2007. Female patient was diagnosed with diabetes mellitus and was treated with EXUBERA. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody, cough, diabetes mellitus inadequate control, hyperglycaemia, lung disorder, . EXUBERA dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
ANTI-INSULIN ANTIBODY : Penfill Side Effects Report #5501550-7
PENFILL problem was reported by a Physician from JAPAN on Oct 22, 2007. Female patient, 77 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with PENFILL. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody, blood glucose fluctuation, . PENFILL dosage: unknown. During the same period patient was treated with NOVORAPID, NOVORAPID CHU. Patient was hospitalized. Patient recovered.
ANTI-INSULIN ANTIBODY : Novorapid Side Effects Report #5502713-7
Consumer or non-health professional from JAPAN reported NOVORAPID problem on Oct 22, 2007. Male patient, 60 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody, epididymal infection, hyperglycaemia, . NOVORAPID dosage: unknown. During the same period patient was treated with NOVOLIN U CHU, HUMALOG. Patient was hospitalized. Patient recovered.
ANTI-INSULIN ANTIBODY : Novorapid Side Effects Report #5452654-9
NOVORAPID CHU FLEXPEN problem was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2007. Male patient, 39 years of age, weighting 156.5 lb, was diagnosed with type 1 diabetes mellitus and was treated with NOVORAPID CHU FLEXPEN. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody, hepatitis, injection site erythema, injection site induration, injection site pruritus, injection site reaction, liver disorder, . NOVORAPID CHU FLEXPEN dosage: unknown. During the same period patient was treated with NOVOLIN N, TICLOPIDINE, GLIMEPIRIDE. Patient recovered.
ANTI-INSULIN ANTIBODY : Humalog Side Effects Report #5456448-X
Consumer or non-health professional from NETHERLANDS reported HUMALOG problem on Sept 05, 2007. Male patient, 51 years of age, was diagnosed with type 1 diabetes mellitus, hypertension, hypercholesterolaemia, impaired gastric emptying and was treated with HUMALOG. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody, hypoglycaemia, . HUMALOG dosage: unknown. During the same period patient was treated with ASPIRIN, COZAAR, EZETROL, LESCOL, METOCLOPRAMIDE. Patient recovered.